Merck has a new drug molecule for SARS-COV-2. It is named Molnupiravir or EIDD-2801. We will discuss the following topics about this drug.
- Need for this anti-viral drug to be used with Remdesivir.
- History of the EIDD-2801.
- Trial for phase II and phase III.
- Route of administration.
- Drug properties.
- Mechanism of action.
- Results in mouse studies.
- Therapeutic index.